PMDA — authorised 27 March 2023
- Marketing authorisation holder: PharmaEssence Japan K.K
- Status: approved
🇯🇵 Besremi in Japan
PMDA authorised Besremi on 27 March 2023
Marketing authorisation
Besremi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in Japan
Frequently asked questions
Is Besremi approved in Japan?
Yes. PMDA authorised it on 27 March 2023.
Who is the marketing authorisation holder for Besremi in Japan?
PharmaEssence Japan K.K holds the Japanese marketing authorisation.